Clinical Trials Logo
  1. Home
  2. Nicotine Withdrawal
  3. NCT04163081

The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments — INITIATE  

Nicotine Dependence, Cigarettes Clinical Trial

Official title:
The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments

Clinical Trial Summary

The INITIATE Study is a randomized controlled trial that is testing an intervention designed to increase long-term abstinence among tobacco smokers seen in emergency departments (ED). The intervention includes a behavioural incentive and tailored follow-up support on long-term smoking abstinence, health, healthcare utilization, and cost. Tobacco-related illnesses cost the healthcare system millions each year. Quitting smoking improves smoking-related outcomes, like the onset or management of heart disease, stroke, lung diseases, and several cancers. There are approximately 16 million visits to Canadian EDs each year; an estimated 3-4 million of these involve smokers. Effective quit smoking interventions exist, but are underutilized. Few hospital EDs in Canada offer tobacco-use interventions. In order for ED staff to offer quit smoking support, interventions need to be simple given the realities of the ED environment. Considering that stopping smoking improves health outcomes, that tobacco-use is an important cause of preventable ED use, and the volume of smokers, Canadian EDs are a missed opportunity in the initiation of quit smoking support. Our intervention has been designed to optimize uptake and smoking abstinence by including the most effective evidence-based behavioural and drug-related approaches, removing specific barriers and challenges that smokers face when trying to quit (e.g., affordability, low confidence and motivation), while packaging the intervention in a quick-to-initiate manner, making it ideal for fast-paced, complex ED environments.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04163081
Study type Interventional
Source Ottawa Heart Institute Research Corporation
Contact
Status Active, not recruiting
Phase N/A
Start date April 19, 2022
Completion date November 2026
View Details
See also
  Status Clinical Trial Phase
Completed NCT05477342 - Reducing Nicotine Addiction in Adolescent Smokers N/A
Completed NCT03011710 - Epidemiology and Acute Oral Effects Electronic Cigarette N/A
Recruiting NCT03194919 - Negotiating a Quit Date or Not in Online Interventions N/A
Recruiting NCT03191825 - Online Lapse Management Intervention N/A
Completed NCT03719391 - United States Pre-Market Tobacco Application Pharmacokinetics N/A
Completed NCT05538702 - Acute Oral Effects of Heated Tobacco Products N/A
Completed NCT02723162 - Translational Neuropsychopharmacology Research of Nicotine Addiction Phase 2
Completed NCT03194958 - Helping Poor Smokers Quit N/A
Completed NCT03593239 - Comparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy Smokers N/A
Completed NCT04830384 - Evaluation of LLLT/Music for Smoking Cessation N/A
Completed NCT02367391 - Penn State TXT2Quit Study N/A
Recruiting NCT05665465 - Neurobehavioral Mechanisms Linking Childhood Adversity to Increased Risk for Smoking Early Phase 1
Completed NCT04805515 - Impact of Nicotine Messaging on Nicotine Beliefs and Tobacco Use Behavior N/A
Completed NCT03700112 - Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods. N/A
Terminated NCT02986711 - Penn State TXT2STAYQUIT Study- a Texting Study to Help Hospitalized Smokers Stay Quit N/A
Recruiting NCT05224154 - Re-Connect Application for Smoking Cessation N/A
Completed NCT03492463 - The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products Phase 2
Withdrawn NCT03473483 - Cigarette Harm Reduction With Electronic Cigarette Use N/A
Completed NCT04379388 - Improving Smoking Cessation in Socioeconomically-Disadvantaged Young Adults N/A